Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/26/2009US20090291932 Pharmaceutical solid state forms
11/26/2009US20090291931 Compositions with enhanced elasticizing activity
11/26/2009US20090291930 Fibrous calcium pyrophosphate particles and methods of making and using same
11/26/2009US20090291929 Steroids having a mixed androgenic and progestagenic profile
11/26/2009US20090291928 Composition for amelioration/prevention of adverse side effect in steroid therapy
11/26/2009US20090291927 Extended cycle multiphasic oral contraceptive kit
11/26/2009US20090291926 High yield and rapid synthesis methods for producing metallo-organic salts
11/26/2009US20090291925 Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions
11/26/2009US20090291924 Drug design for tubulin inhibitors, compositions, and methods of treatment thereof
11/26/2009US20090291923 Trioxane dimers having high anticancer and long-lasting antimalarial activities
11/26/2009US20090291922 Anti-proliferative compounds, compositions, and methods of use thereof
11/26/2009US20090291921 Integrase inhibitors
11/26/2009US20090291920 Detection of steroid receptors on circulating carcinoma cells and treatment
11/26/2009US20090291919 Compositions and Methods for Treating or Preventing Ophthalmic Light Toxicity
11/26/2009US20090291918 Proteasome inhibitors and methods of using the same
11/26/2009US20090291917 Boron-Containing Small Molecules as Anti-Inflammatory Agents
11/26/2009US20090291916 Trihydroxy Polyunsaturated Eicosanoid
11/26/2009US20090291915 Silicon Compounds and Their Use
11/26/2009US20090291914 Hyaluronic acid oligosaccharide fractions and drugs containing the same
11/26/2009US20090291913 FACTOR Xa INHIBITOR FORMULATION AND METHOD
11/26/2009US20090291912 Chitosan-containing protective composition
11/26/2009US20090291911 Rehydratable polysaccharide particles and sponge
11/26/2009US20090291910 Agent and food for preventing/improving functional digestive disorder
11/26/2009US20090291909 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
11/26/2009US20090291908 Use of thiophoshonoformic acid and nrtis to treat viral infections
11/26/2009US20090291907 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
11/26/2009US20090291906 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
11/26/2009US20090291905 Fungal phytotoxin fusicoccin for the treatment and diagnosis of coagulation-correlated pathologies
11/26/2009US20090291904 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
11/26/2009US20090291903 Substituted pyrrolidine amides as modulators of the histamine h3 receptor
11/26/2009US20090291893 Compositions for the prevention and treatment of neuroinjury and methods of use thereof
11/26/2009US20090291891 VEGF variant that lacks VEGFR-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis
11/26/2009US20090291889 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1)
11/26/2009US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use
11/26/2009US20090291883 Combination of an immunosuppressive agent and nonsteroidal anti -inflammatory drugs to treat disease
11/26/2009US20090291882 Coatings for drug delivery devices
11/26/2009US20090291877 Treatments using citrulline
11/26/2009US20090291155 containing extract of leaves of the plant Polyalthia longifolia comprising a compound, 16-hydroxycleroda-3,13(14)-dien-15,16-olide, as a bioactive marker and optionally other active(s) for effective treatment of inflammatory disorders
11/26/2009US20090291153 Health food, Method for producing the same and dried Product and Extract
11/26/2009US20090291152 Dibenzothiazepine derivatives
11/26/2009US20090291146 Process for manufacturing lactose
11/26/2009US20090291145 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
11/26/2009US20090291144 Therapeutic and Prophylactic Compositions Including Catalytic Biomimetic Solids and Methods to Prepare and Use Them
11/26/2009US20090291143 Combination of Azelastine and Steroids
11/26/2009US20090291140 Treatment of dysmenorrhea via transdermal administration of nonsteroidal anti-inflammatory drugs
11/26/2009US20090291139 Sparc and methods of use thereof
11/26/2009US20090291138 Film-coated preparation having improved stability
11/26/2009US20090291136 Multiple Unit Tablets
11/26/2009US20090291135 Direct compression polymer tablet core
11/26/2009US20090291134 Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
11/26/2009US20090291132 Enhanced delivery of antifungal agents
11/26/2009US20090291131 Silencing of polo-like kinase expression using interfering rna
11/26/2009US20090291129 Formulation of insoluble small molecule therapeutics in lipid-based carriers
11/26/2009US20090291128 Transdermal delivery of cannabinoids
11/26/2009US20090291127 Transdermal anti-dementia active agent formulations and methods for using the same
11/26/2009US20090291126 Adhesive pharmaceutical preparation containing bisoprolol
11/26/2009US20090291121 Capsule and coated capsules as a delivery system for dietary supplements and therapeutic materials
11/26/2009US20090291119 Polymeric implant and a process for obtaining a polymeric implant
11/26/2009US20090291110 One swipe anti-bacteria disposable toilet seat wipe
11/26/2009US20090291102 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
11/26/2009US20090291094 Antibodies and processes for preparing the same
11/26/2009US20090291079 Phosphatidylinositol 3 (PI3); Mammalian Target of Rapamycin, mTOR; triazine compounds substituted with either morpholino or tetrahydropyranyl rings on the triazine ring; anticancer agents, atherosclerosis, bone disorders, psoriasis, BPH, pancreatitis, kidney disease
11/26/2009US20090291074 Mutations in oas1 genes
11/26/2009US20090291073 Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
11/26/2009US20090291066 composition and method of treating facial skin defect
11/26/2009US20090291063 Compositions and methods for the treatment of viral hepatitis
11/26/2009US20090291053 Low molecular weight ampholytic polymers for personal care applications
11/26/2009US20090291050 Particulate materials
11/26/2009US20090291049 Targeted delivery to human diseases and disorders
11/26/2009US20090291020 Soft contact lens solution containing hyaluronic acid
11/26/2009US20090288658 Antibiotic Formulations, Unit Doses, Kits, and Methods
11/26/2009DE10317922B4 Verwendung eines Kombinationspräparates aus oralem Kontrazeptivum und Calcium/Vitamin D The use of a combination product of oral contraceptive and calcium / vitamin D
11/26/2009CA2762321A1 Fosphenytoin composition
11/26/2009CA2761971A1 Rice bran extracts for inflammation and methods of use thereof
11/26/2009CA2759877A1 Standardized extract and fraction from hancornia speciosa leaves and pharmaceutical composition thereof
11/26/2009CA2725726A1 Tricyclic nitrogen containing compounds and their use as antibacterials
11/26/2009CA2725535A1 Modified drugs for use in liposomal nanoparticles
11/26/2009CA2725534A1 Inhibition of emmprin to treat multiple sclerosis
11/26/2009CA2725529A1 Liposomes for drug delivery and methods for preparation thereof
11/26/2009CA2725282A1 Thermoplastic paste for repairing live tissues
11/26/2009CA2725185A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
11/26/2009CA2725138A1 Compositions and methods of treatment using modulators of motoneuron diseases
11/26/2009CA2725125A1 Colon cleansing method and kit
11/26/2009CA2725066A1 Bicyclic compounds having activity at the cxcr4 receptor
11/26/2009CA2725047A1 Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same
11/26/2009CA2725045A1 Silent desensitizers of neuronal nachr and methods of use thereof
11/26/2009CA2725001A1 Dihydroindolone derivatives
11/26/2009CA2724983A1 Composition for preventing cardiovascular event in high-risk patient
11/26/2009CA2724971A1 Standardized extract and fraction from hancornia speciosa leaves and pharmaceutical composition thereof
11/26/2009CA2724955A1 Method of treating anxious major depressive disorder
11/26/2009CA2724897A1 Salts and polymorphs of a tetracycline compound
11/26/2009CA2724842A1 Imidazo[1,2-a]pyridine compounds
11/26/2009CA2724840A1 Separation of polysaccharides by charge density gradient
11/26/2009CA2724821A1 Polymer derivative of docetaxel, method of preparing the same and uses thereof
11/26/2009CA2724812A1 Co-crystals of duloxetine and cox-inhibitors for the treatment of pain
11/26/2009CA2724788A1 Hepatoprotectant acetaminophen mutual prodrugs
11/26/2009CA2724785A1 Selective caspase inhibitors and uses thereof
11/26/2009CA2724784A1 Antimicrobial compositions and methods of use
11/26/2009CA2724756A1 3, 4 - substituted piperidine derivatives as renin inhibitors
11/26/2009CA2724742A1 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
1 ... 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 ... 7860